PrivatepeptideClinic Peptide Clinics Pty Ltd, an entity that operated within Australia and South Africa, has become a notable subject due to significant legal and regulatory actions regarding its operations. The company, which presented itself as a provider of peptides and other therapeutic substances, faced substantial penalties for alleged breaches of advertising and therapeutic goods regulations2018年12月14日—Peptide ClinicsAustralia is alleged to have advertised compounded prescription only therapeutic goods, including 'peptides', on its website and other social .... This has led to its deregistration and liquidation in Australia, serving as a critical case study on compliance within the pharmaceutical and wellness industries.PEPTIDE CLINICS PTY. LTD. - ABN 19165404286
The Therapeutic Goods Administration (TGA) in Australia took significant action against Peptide Clinics Pty Ltd.BPC 157 in Australia: Benefits, side effects, risks and legality In July 2019, the Federal Court ordered the company to pay a $10 million penalty for breaching mandatory rulesPeptide Clinics wasan Australian company that offered peptides and other substances for sale onlineas supplements for medical purposes.. These breaches primarily involved the advertising of compounded prescription-only therapeutic goods, including peptides, on its website and social media platforms2021年9月7日—During this same period Mr Abrams also became a director and shareholder ofPeptides Clinics Pty Ltd, an online business that maintained a .... The TGA alleged that Peptide Clinics operated an online retail business that promoted these substances inappropriately, potentially leading to serious harm to consumers' healthCurrent details for ABN 19 165 404 286. The company was also found to be using doctors who were banned from prescribing peptides, further compounding the regulatory violations.
Records indicate that PEPTIDE CLINICS PTY. LTD. (ABN 19 165 404 286) was an Australian Private Company. Its status has been marked as Cancelled from August 2021 and Deregistered by August 2022. Prior to this, in March 2019, the company was noted as being in liquidation. These statuses reflect the culmination of the regulatory pressures and legal proceedings it faced.
While the Australian entity faced dissolution, a related entity, Peptide Clinics South Africa Pty Ltd, appears to have continued operations. This South African branch describes itself as a sterile pharmaceutical compounding lab located in Johannesburg, specializing in the sale of peptides for various health goals. It provides contact information, including a WhatsApp number and email, for inquiries and servicesTGA uses its power to penalise inappropriate online ....
The case of Peptide Clinics Pty Ltd highlights the complex regulatory landscape surrounding peptides. Peptides are short chains of amino acids that can have various biological functions, leading to their use in therapeutic and cosmetic applications.GET IN TOUCH. WHATSAPP US · +27 10 100 3108 · SEND US AN EMAIL · [email protected] Clinics South Africa Pty Ltd2018/023869/07. However, many peptides are considered prescription-only medicines or unapproved therapeutic goods, requiring strict controls on their advertising and sale. Companies operating in this space must navigate stringent regulations, such as those enforced by the TGA in Australia, to avoid severe penalties. The incident underscores the importance of legitimate peptide therapy providers adhering to TGA compliance, doctor credentials, and ethical marketing practices.
Peptide Clinics Pty Ltd's history serves as a significant cautionary taleTristan Dimmock's Post. The substantial penalties and subsequent deregistration of the Australian entity underscore the critical importance of regulatory compliance in the sale and advertising of therapeutic goods.2019年5月17日—Usingpeptidesand other prescription-only therapeutic goods sold byPeptide ClinicsAustralia could result in serious harm to consumers' health ... While a related entity continues to operate in South Africa, the Australian experience emphasizes the risks associated with non-compliance, particularly when dealing with substances that fall under strict therapeutic goods legislation. Consumers seeking peptide therapies are advised to engage with legitimate providers who prioritize safety, ethical practices, and adherence to all relevant regulatory frameworksHas anyone bought peptides from Peptide Clinics Australia?.
Join the newsletter to receive news, updates, new products and freebies in your inbox.